Implementation of a telephone-based secondary preventive intervention after acute coronary syndrome (ACS): participation rate, reasons for non-participation and 1-year survival

Table 1 Patient characteristics

	Included		Excluded		Declined		p	p	p
	N	% or SD	n	% or SD	n	% or SD	i/e	i/d	d/e
Subjects	661	72.9	146	16.1	100	11
Gender (male)	453	68.5	80	54.8	47	53	0.002	<0.001	0.230
Mean age (years ± SD)	69.2 ± 11.9		76.3 ± 12.1		77.3 ± 11.7		<0.001	<0.001	0.499
Basic characteristics
mRS >3	7	1.1	33	22.6	8	8.0	<0.001	<0.001	0.003
eGFR	78.4 ± 21.3		68.9 ± 22.9		70.4 ± 21.5		<0.001	0.001	0.597
eGFR <60	128	19.4	52	35.6	29	29	<0.001	0.026	0.278
eGFR 60–90	308	46.6	66	45.2	50	50	0.76	0.525	0.459
eGFR >90	225	34.0	28	19.2	21	21	<0.001	0.009	0.725
BMI (mean ± SD)	27.3 ± 4.5		25.8 ± 5.2		26.4 ± 5		0.001	0.077	0.375
BMI <18.5	5 ± 0.8		14 ± 10.1		3 ± 3.1		<0.001	0.070	0.044
BMI 18.5–25	206 ± 31.2		49 ± 35.3		34 ± 35.1		0.347	0.442	0.975
BMI 25–30	295 ± 44.6		53 ± 38.1		39 ± 40.2		0.160	0.413	0.748
BMI >30	155 ± 23.4		23 ± 16.5		21 ± 21.6		0.075	0.695	0.322
Only basic education	345	52.2	99	67.8	77	77.0	<0.001	<0.001	0.231
Heredity (first line)	178	27.3	28	21.5	20	21.5	0.173	0.237	0.995
Previous morbidities
Previous IHD	156	23.6	51	34.9	34	34.0	0.005	0.025	0.880
Current NSTEMI	420	63.5	100	68.5	69	69.0	0.258	0.288	0.933
Current STEMI	182	27.5	42	28.8	25	25.0	0.763	0.596	0.514
Previous stroke	48	7.3	26	17.8	15	15.0	<0.001	0.009	0.562
Peripheral artery disease	15	2.3	8	5.5	5	5.0	0.035	0.112	0.869
Congestive heart failure CHF (Previous)	23	3.5	20	13.7	10	10.0	<0.001	0.003	0.384
Smoking (current/previous)	414	62.6	79	54.1	57	57.0	0.065	0.272	0.697
Atrial fibrillation	95	14.8	42	29.4	26	26.0	<0.001	0.002	0.701
Hyperlipidemia	463	96.1	110	96.5	80	100	0.829	0.071	0.090
Hypertension	354	53.6	95	65.1	67	67.0	0.011	0.012	0.754
Diabetes	135	20.4	45	30.8	28	28.0	0.006	0.085	0.634

p values for comparison: i/e, included versus excluded; i/d, included versus declined; d/e, declined versus excluded. Hyperlipidemia: treatment initiated or untreated total cholesterol >4.5 mmol/L or untreated LDL cholesterol >2.5 mmol/L
BMI body mass index, eGFR estimated glomerular filtration rate, IHD ischemic heart disease, LDL low-density lipoprotein, mRS modified Rankin scale, NSTEMI non-ST-elevation myocardial infarction, SD standard deviation, STEMI ST-elevation myocardial infarction

ISSN: 1745-6215